| JAGSNPHARM | | | 213.70 17.70 7.65% |
Jagsonpal Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Jagsonpal Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Jagsonpal Pharmaceuticals is a good investment. Please check the relationship between Jagsonpal Pharmaceuticals Total Operating Expenses and its Net Income From Continuing Ops accounts. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jagsonpal Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Total Operating Expenses vs Net Income From Continuing Ops
Total Operating Expenses vs Net Income From Continuing Ops Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Jagsonpal Pharmaceuticals Total Operating Expenses account and
Net Income From Continuing Ops. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Jagsonpal Pharmaceuticals' Total Operating Expenses and Net Income From Continuing Ops is 0.17. Overlapping area represents the amount of variation of Total Operating Expenses that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Jagsonpal Pharmaceuticals Limited, assuming nothing else is changed. The correlation between historical values of Jagsonpal Pharmaceuticals' Total Operating Expenses and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Operating Expenses of Jagsonpal Pharmaceuticals Limited are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Total Operating Expenses i.e., Jagsonpal Pharmaceuticals' Total Operating Expenses and Net Income From Continuing Ops go up and down completely randomly.
Correlation Coefficient | 0.17 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Net Income From Continuing Ops
Most indicators from Jagsonpal Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Jagsonpal Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jagsonpal Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
As of now, Jagsonpal Pharmaceuticals'
Tax Provision is increasing as compared to previous years. The Jagsonpal Pharmaceuticals' current
Issuance Of Capital Stock is estimated to increase to about 68
M, while
Selling General Administrative is projected to decrease to under 32.5
M.
Jagsonpal Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Jagsonpal Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Jagsonpal Pharmaceuticals fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Jagsonpal Stock
Balance Sheet is a snapshot of the
financial position of Jagsonpal Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Jagsonpal Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Jagsonpal Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Jagsonpal currently owns. An asset can also be divided into two categories, current and non-current.